Trial · NCT00399893
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Participants With Decrease in Fasting Total Ghrelin | 6 months | Number of participants showing a decrease in Fasting total ghrelin from baseline to 6 months of treatment with Octreotide or placebo |
| Primary | Number of Participants With Decrease in Weight From Baseline to 6 Months | 6 months | Number of participants who had a decrease in weight from baseline to 6 months of Octreotide or placebo therapy |
| Primary | Number of Participants With Decreased BMI Z-score From Baseline to 6 Months | 6 months | Number of participants with decreased BMI z-score from baseline to 6 months of Octreotide or Placebo therapy |
| Primary | Number of Participants With Decreased Skin-fold Measurements From Baseline to 6 Months | 6 months | Number of participants with decreased skin-fold measurements from baseline to 6 months of Octreotide or Placebo therapy |
| Primary | Number of Participants With Decrease in Hunger and Food Intake | 6 months | Measured by hunger and hyperphagia by questionnaires and parent-reported 72-hour food recall from baseline to 6 months. Multiple questionnaires consisting of a battery of free text answer questions and food diaries are combined in order to make a behavioral assessment of the participants food state of hunger and food intake. There is no defined scale for this assessment. Each participants responses and parent responses are combined. |
| Primary | Number of Participants With Improved Insulin Regulation From Baseline to 6 Months | 6 months | Number of participants with improved Insulin regulation from baseline to 6 months of Octreotide or Placebo therapy. Insulin regulation was measured by immunochemiluminescent assay. |
| Primary | Number of Participants With Improved Adiponectin Regulation From Baseline to 6 Months | 6 months | Number of participants with improved Adiponectin regulation from baseline to 6 months of Octreotide or Placebo therapy |
| Primary | Number of Participants With Improved Leptin Regulation From Baseline to 6 Months | 6 months | Number of participants with improved Leptin regulation from baseline to 6 months of Octreotide or Placebo therapy |
| Primary | Number of Participants With Improved Peptide YY (PYY) Regulation From Baseline to 6 Months | 6 months | Number of participants with improved Peptide YY (PYY) regulation from baseline to 6 months of Octreotide or Placebo therapy |
| Secondary | Number of Participants With Decreased Body Composition From Baseline to 6 Months by BOD POD® | 6 months | Number of participants with decreased body-composition as Measured by BOD POD® body composition tracking system from baseline to 6 months of Octreotide or Placebo therapy |
| Secondary | Number of Participants With Decreased Body-composition From Baseline to 6 Months by DEXA | 6 months | Number of participants with decreased body-composition as Measured by Dual Energy X-ray Absorptiometry (DEXA) scan from baseline to 6 months of Octreotide or Placebo therapy |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00399893/registered